744 related articles for article (PubMed ID: 31530793)
21. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
22. Roles of microRNAs in Regulating Cancer Stemness in Head and Neck Cancers.
Fitriana M; Hwang WL; Chan PY; Hsueh TY; Liao TT
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917482
[TBL] [Abstract][Full Text] [Related]
23. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
24. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
25. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
26. Targeting cancer stem cell pathways for cancer therapy.
Yang L; Shi P; Zhao G; Xu J; Peng W; Zhang J; Zhang G; Wang X; Dong Z; Chen F; Cui H
Signal Transduct Target Ther; 2020 Feb; 5(1):8. PubMed ID: 32296030
[TBL] [Abstract][Full Text] [Related]
27. microRNA: The Impact on Cancer Stemness and Therapeutic Resistance.
Jiao X; Qian X; Wu L; Li B; Wang Y; Kong X; Xiong L
Cells; 2019 Dec; 9(1):. PubMed ID: 31861404
[TBL] [Abstract][Full Text] [Related]
28. [MicroRNAs Regulation of Cancer Stem Cells].
Zhang JP; Jia YS; Tong ZS
Sheng Li Ke Xue Jin Zhan; 2015 Feb; 46(1):17-22. PubMed ID: 26103721
[TBL] [Abstract][Full Text] [Related]
29. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
30. The role of microRNAs in breast cancer stem cells.
Schwarzenbacher D; Balic M; Pichler M
Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells.
Xu W; Ji J; Xu Y; Liu Y; Shi L; Liu Y; Lu X; Zhao Y; Luo F; Wang B; Jiang R; Zhang J; Liu Q
Mol Carcinog; 2015 Jun; 54 Suppl 1():E148-61. PubMed ID: 25252218
[TBL] [Abstract][Full Text] [Related]
32. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
33. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
34. SFRP1 in Skin Tumor Initiation and Cancer Stem Cell Regulation with Potential Implications in Epithelial Cancers.
Sunkara RR; Sarate RM; Setia P; Shah S; Gupta S; Chaturvedi P; Gera P; Waghmare SK
Stem Cell Reports; 2020 Feb; 14(2):271-284. PubMed ID: 31928951
[TBL] [Abstract][Full Text] [Related]
35. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
[TBL] [Abstract][Full Text] [Related]
36. Nanog, as a key cancer stem cell marker in tumor progression.
Vasefifar P; Motafakkerazad R; Maleki LA; Najafi S; Ghrobaninezhad F; Najafzadeh B; Alemohammad H; Amini M; Baghbanzadeh A; Baradaran B
Gene; 2022 Jun; 827():146448. PubMed ID: 35337852
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
38. Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.
Christensen AG; Ehmsen S; Terp MG; Batra R; Alcaraz N; Baumbach J; Noer JB; Moreira J; Leth-Larsen R; Larsen MR; Ditzel HJ
Stem Cells; 2017 Aug; 35(8):1898-1912. PubMed ID: 28600813
[TBL] [Abstract][Full Text] [Related]
39. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
40. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
